Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Conceptus CEO hired

This article was originally published in The Gray Sheet

  • News

Executive Summary

Former Bausch & Lomb President, Americas, Mark Sieczkarek, 48, is appointed president, CEO and board member of the Essure non-incisional birth control company, effective April 17. Former president and CEO Steven Bacich will become the firm's chief technology officer. The San Carlos, Calif. firm says Sieczkarek's experience in overseeing the launch of B&L's Zyoptix laser for LASIK eye surgery will serve him in marketing Essure, approved last November (1"The Gray Sheet" Nov. 11, 2002, p. 16)...

Table

View full table

Tags:
Latest Headlines

ICER Debuts Clinical Trial Diversity Assessment Framework

UK MHRA’s Strategic Approach To AI Will Be ‘Proportionate’ And Fit Well Internationally

Attorney: Proposed Data Privacy Law Would Ultimately Reduce Regulatory Burden

Senseonics Wins Marketing Authorization For Novel Insulin Delivery System

See All
UsernamePublicRestriction

Register

MT018225

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By